Tissue expression
Cell line expression

AKT1

gene product
AKT, PKB, PRKBA, RAC, RAC-alpha 
This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antigen sequence

Epitope

Antibody

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
5395 antibodies from 56 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Proteintech Group
15 antibodies
Invitrogen Antibodies
203 antibodies
antibodies-online
1814 antibodies
GeneTex
39 antibodies
Novus Biologicals
190 antibodies
Cell Signaling Technology, Inc
61 antibodies
R&D Systems
28 antibodies
OriGene
171 antibodies
Abnova Corporation
68 antibodies
Atlas Antibodies
3 antibodies
Cusabio Biotech Co., Ltd
53 antibodies
NovoPro Bioscience Inc.
41 antibodies
LifeSpan BioSciences, Inc.
726 antibodies
Biorbyt
320 antibodies
Aviva Systems Biology
67 antibodies
NSJ Bioreagents
21 antibodies
Abgent
43 antibodies
Enzo Life Sciences
6 antibodies
Boster Biological Technology
24 antibodies
HUABIO Research
6 antibodies
Affinity Biosciences
20 antibodies
Wuhan Fine Biotech Co., Ltd.
5 antibodies
Acris Antibodies GmbH
119 antibodies
St John's Laboratory
68 antibodies
Signalway Antibody LLC
10 antibodies
ProSci
15 antibodies
SignalChem
6 antibodies
Bioworld Technology, Inc
21 antibodies
Rockland Immunochemicals, Inc.
46 antibodies
Bethyl Laboratories
2 antibodies
BioLegend
4 antibodies
ABEOMICS Inc.
2 antibodies
RabMAbs
23 antibodies
Abbkine Scientific Co.Ltd.
37 antibodies
Creative Biolabs
176 antibodies
MilliporeSigma / Merck KGaA
36 antibodies
MyBioSource
85 antibodies
Creative Diagnostics
36 antibodies
United States Biological
379 antibodies
GenWay
27 antibodies
EMD Millipore
24 antibodies
FabGennix
6 antibodies
Abbexa
99 antibodies
Everest Biotech
1 antibody
Leading Biology
36 antibodies
Abbiotec
5 antibodies
Miltenyi Biotec
20 antibodies
Spring Bioscience
4 antibodies
RayBiotech, Inc.
6 antibodies
DB Biotech
2 antibodies
Abiocode, Inc.
1 antibody
Exalpha Biologicals, Inc.
4 antibodies
Active Motif
1 antibody
CPTAC
6 antibodies